DiaMedica Therapeutics Inc. Common Stock DMAC
$6.68
-1.04%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | Insider transaction | 2026-08-12 | View → |
| 10-Q | FORM 10-Q | 2026-08-10 | View → |
| 8-K | FORM 8-K | 2026-08-10 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-06-03 | View → |
| 8-K | FORM 8-K | 2026-05-21 | View → |
| 10-Q | FORM 10-Q | 2026-05-06 | View → |
| 8-K | FORM 8-K | 2026-05-06 | View → |
| DEF 14A | FORM DEF 14A | 2026-04-01 | View → |
| 8-K | FORM 8-K | 2026-03-31 | View → |
| 10-K | FORM 10-K | 2026-03-30 | View → |
| 4 | Insider transaction | 2026-01-06 | View → |
| 4 | Insider transaction | 2026-01-06 | View → |
| 4 | Insider transaction | 2026-01-06 | View → |
| 8-K | FORM 8-K | 2026-01-05 | View → |
| 8-K | FORM 8-K | 2025-12-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-12-08 | View → |
| 4 | Insider transaction | 2025-11-25 | View → |
| 10-Q | FORM 10-Q | 2025-11-12 | View → |
| 8-K | FORM 8-K | 2025-11-12 | View → |
| 4 | Insider transaction | 2025-11-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-09-04 | View → |
| 8-K | FORM 8-K | 2025-08-12 | View → |
| S-3 | FORM S-3 | 2025-08-12 | View → |
| 10-Q | FORM 10-Q | 2025-08-12 | View → |
| 8-K | FORM 8-K | 2025-08-12 | View → |
| 8-K | FORM 8-K | 2025-08-06 | View → |
| S-3 | FORM S-3 | 2025-08-01 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-07-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-07-25 | View → |
| 4 | FORM 4 | 2025-07-25 | View → |
| 8-K | FORM 8-K | 2025-07-21 | View → |
| 8-K | FORM 8-K | 2025-07-17 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $6.68
- Market Cap
- $368.85 million
- 52-Week Range
- $3.58 – $10.42
- Average Volume
- 187K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.